January 2024

Shorla Oncology

Shorla FDA Filing to Treat Breast and Ovarian Cancer

Latest News, Shorla Pharma /

U.S.-Ireland Specialty Pharmaceutical Company’s ready-to-dilute form of a drug for the treatment of adenocarcinoma of the breast or ovary January 9, 2024 – CAMBRIDGE, Mass. – Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for a […]

Shorla FDA Filing to Treat Breast and Ovarian Cancer Read More »

Endotronix 2

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System.

Endotronix, Latest News /

Naperville, Illinois, USA.   5 January, 2024.  Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the submission of a Premarket Approval (PMA) application for its Cordella™ Pulmonary Artery (PA) Sensor System to the U.S. Food and Drug Administration (FDA). Cordella is

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System. Read More »

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top